This compound is a phosphoramidite-modified purine nucleoside derivative used as an oligonucleotide building block intermediate. It features a protected guanine base and a morpholino ring system with a trityl protecting group, enabling selective incorporation into synthetic oligonucleotide chains.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-[9-[(2R,6S)-6-[[chloro(dimethylamino)phosphoryl]oxymethyl]-4-tritylmorpholin-2-yl]-6-oxo-1H-purin-2-yl]-2-phenylacetamide
pharmaceutical intermediate
(6-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate)
pharmaceutical intermediate
5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid
pharmaceutical intermediate
2'-Deoxythymidine-5'-diphosphate trisodium salt
pharmaceutical intermediate
6-CHLORO-2-METHOXYNICOTINALDEHYDE
pharmaceutical intermediate
N-[9-[(2R,6S)-6-[[chloro(dimethylamino)phosphoryl]oxymethyl]-4-tritylmorpholin-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
JEXKEVAZWLLEBW-OXJZQVEGSA-N
CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2[C@H]3CN(C[C@H](O3)COP(=O)(N(C)C)Cl)C(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.